Zhengye Biotechnology Holding (ZYBT) Construction in Progress (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has reported Construction in Progress for 3 consecutive years, with $86005.5 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Construction in Progress fell 93.67% year-over-year to $86005.5 in Q4 2025; TTM through Dec 2025 was $86005.5, a 93.67% decrease from a year earlier, with the FY2025 full-year figure at $87000.0, down 93.49% from the prior year.
• Construction in Progress was $86005.5 for Q4 2025 at Zhengye Biotechnology Holding, down from $1.4 million in the prior quarter.
• Over five years, Construction in Progress peaked at $1.4 million in Q4 2024 and troughed at $86005.5 in Q4 2025.
• A 3-year average of $833801.2 and a median of $1.1 million in 2023 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress increased 28.35% in 2024 and tumbled 93.67% in 2025, its largest moves.
• Over 3 years, Construction in Progress stood at $1.1 million in 2023, then grew by 28.35% to $1.4 million in 2024, then plunged by 93.67% to $86005.5 in 2025.
• The last three Construction in Progress figures came in at $86005.5 (Q4 2025), $1.4 million (Q4 2024), and $1.1 million (Q4 2023), per Business Quant data.